Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia
- 9 November 2006
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 20 (14) , 2657-2659
- https://doi.org/10.1096/fj.06-6568fje
Abstract
The critical role of vascular endothelial growth factor (VEGF) expression levels in developmental angiogenesis is well established. Nonetheless, the effects of different local (microenvironmental) VEGF concentrations in ischemia have not been studied in the adult organism, and VEGF delivery to patients has been disappointing. Here, we demonstrate the existence of both lower and upper threshold levels of microenvironmental VEGF concentrations for the induction of therapeutic vessel growth in ischemia. In the ischemic hind limb, implantation of myoblasts transduced to express VEGF164 at different levels per cell increased blood flow only moderately, and vascular leakage and aberrant preangiomatous vessels were always induced. When the same total dose was uniformly distributed by implanting a monoclonal population derived from a single VEGF-expressing myoblast, blood flow was fully restored to nonischemic levels, collateral growth was induced, and ischemic damage was prevented. Hemangiomas were avoided and only normal, pericyte-covered vessels were induced persisting over 15 mo. Surprisingly, clones uniformly expressing either lower or higher VEGF levels failed to provide any functional benefit. A biphasic effect of VEGF dose on vessel number and diameter was found. Blood flow was only improved if vessels were increased both in size and in number. Microenvironmental VEGF concentrations determine efficacy and safety in a therapeutic setting.—von Degenfeld, G., Banfi, A., Springer, M. L., Wagner, R. A., Jacobi, J., Ozawa, C. R., Merchant, M. J., Cooke, J. P., Blau, H. M. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia.Keywords
Funding Information
- National Institutes of Health (AG009521, HL065572, HD018179, AG020961, AG024987)
- Donald E. and Delia B. Baxter Foundation
This publication has 35 references indexed in Scilit:
- Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscleGene Therapy, 2005
- Effects of gene delivery on collateral development in chronic hypoperfusionDiverse effects of angiopoietin-1 versus vascular endothelial growth factorJournal of the American College of Cardiology, 2004
- Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesisJournal of Clinical Investigation, 2004
- Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbitsHeart and Vessels, 2003
- Angiogenic Gene Therapy for Experimental Critical Limb IschemiaCirculation Research, 2002
- Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapyThe EMBO Journal, 2002
- Role of Ischemia and of Hypoxia-Inducible Genes in Arteriogenesis After Femoral Artery Occlusion in the RabbitCirculation Research, 2001
- Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formationJournal of the American College of Cardiology, 2000
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996